Bioregenx (BRGX) Income towards Parent Company (2022 - 2026)
Bioregenx (BRGX) recorded quarterly Income towards Parent Company of -$126850.0 in Q1 2026, up 87.54% quarter-over-quarter from -$1.0 million in Q4 2025, and up 52.46% on a YoY basis from -$83199.6 in Q1 2025.
Bioregenx (BRGX) Income towards Parent Company (2022 - 2026) Analysis & Trends
Bioregenx's Income towards Parent Company history runs 5 years deep, the most recent figure standing at -$126850.0 for Q1 2026.
- In Q1 2026, Income towards Parent Company rose 52.46% year-over-year to -$126850.0; the TTM figure through Mar 2026 stood at -$1.4 million (up 93.04% YoY), while the FY2025 annual figure was -$1.5 million, up 93.3% from the prior year.
- Income towards Parent Company was -$126850.0 for Q1 2026 at Bioregenx, up from -$1.0 million in the prior quarter.
- In the past five years, Income towards Parent Company ranged from a high of -$2191.0 in Q3 2022 to a low of -$18.4 million in Q4 2024.
- Historically, Income towards Parent Company has averaged -$1.4 million across 5 years, with a median of -$178345.0 in 2025.
- The sharpest annual moves came in 2024 and 2025: Income towards Parent Company slumped 26695.74% in 2024, then surged 94.47% in 2025.
- A 5-year view of Income towards Parent Company shows it stood at -$5535.0 in 2022, then slumped by 12907.52% to -$719966.0 in 2023, then plunged by 2455.76% to -$18.4 million in 2024, then soared by 94.47% to -$1.0 million in 2025, then surged by 87.54% to -$126850.0 in 2026.
- The last three Income towards Parent Company figures came in at -$126850.0 (Q1 2026), -$1.0 million (Q4 2025), and -$80565.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 26.11 Bn | 18.79 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 12.95 Bn | 12.07 Bn | 482.22 Mn |
| 3 | Healthequity | 7.46 Bn | 7.19 Bn | 256.31 Mn |
| 4 | Hinge Health | 5.15 Bn | 4.83 Bn | 154.23 Mn |
| 5 | Doximity | 3.75 Bn | 3.00 Bn | 125.97 Mn |
| 6 | 10x Genomics | 3.69 Bn | 3.15 Bn | 106.18 Mn |
| 7 | Waystar Holding | 3.61 Bn | 3.45 Bn | 268.04 Mn |
| 8 | Privia Health | 2.90 Bn | 2.54 Bn | 595.71 Mn |
| 9 | Omnicell | 1.72 Bn | 1.54 Bn | 140.36 Mn |
| 10 | Bioregenx | - | - | 348,288.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -126,850.00 |
| Dec 31, 2025 | -1.02 Mn |
| Sep 30, 2025 | -80,565.00 |
| Jun 30, 2025 | -178,345.00 |
| Mar 31, 2025 | -266,854.00 |
| Dec 31, 2024 | -18.40 Mn |
| Sep 30, 2024 | -394,860.00 |
| Jun 30, 2024 | -1.11 Mn |
| Mar 31, 2024 | -704,806.00 |
| Dec 31, 2023 | -719,966.00 |
| Sep 30, 2023 | -3,691.00 |
| Jun 30, 2023 | -4,128.00 |
| Mar 31, 2023 | -229,838.00 |
| Dec 31, 2022 | -5,535.00 |
| Sep 30, 2022 | -2,191.00 |
| Jun 30, 2022 | -33,263.00 |
| Mar 31, 2022 | -37,319.00 |